vs
ONTO INNOVATION INC.(ONTO)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
ONTO INNOVATION INC.的季度营收约是REPLIGEN CORP的1.1倍($218.2M vs $197.9M),ONTO INNOVATION INC.净利率更高(12.9% vs 6.7%,领先6.2%),REPLIGEN CORP同比增速更快(13.6% vs -13.5%),ONTO INNOVATION INC.自由现金流更多($82.0M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 2.6%)
Onto Innovation是一家美国半导体企业,2019年由Rudolph Technologies与Nanometrics合并组建,为微电子制造行业提供生产工艺、工艺控制相关设备及配套软件解决方案,是全球半导体制造支撑领域的重要供应商。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
ONTO vs RGEN — 直观对比
营收规模更大
ONTO
是对方的1.1倍
$197.9M
营收增速更快
RGEN
高出27.1%
-13.5%
净利率更高
ONTO
高出6.2%
6.7%
自由现金流更多
ONTO
多$64.5M
$17.6M
两年增速更快
RGEN
近两年复合增速
2.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $218.2M | $197.9M |
| 净利润 | $28.2M | $13.3M |
| 毛利率 | 50.7% | 52.5% |
| 营业利润率 | 10.9% | 9.0% |
| 净利率 | 12.9% | 6.7% |
| 营收同比 | -13.5% | 13.6% |
| 净利润同比 | -46.8% | 143.9% |
| 每股收益(稀释后) | $0.57 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ONTO
RGEN
| Q4 25 | — | $197.9M | ||
| Q3 25 | $218.2M | $188.8M | ||
| Q2 25 | $253.6M | $182.4M | ||
| Q1 25 | $266.6M | $169.2M | ||
| Q4 24 | $263.9M | $174.1M | ||
| Q3 24 | $252.2M | $154.9M | ||
| Q2 24 | $242.3M | $154.1M | ||
| Q1 24 | $228.8M | $151.3M |
净利润
ONTO
RGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $28.2M | $14.9M | ||
| Q2 25 | $33.9M | $14.9M | ||
| Q1 25 | $64.1M | $5.8M | ||
| Q4 24 | $48.8M | $-30.3M | ||
| Q3 24 | $53.1M | $-654.0K | ||
| Q2 24 | $52.9M | $3.3M | ||
| Q1 24 | $46.9M | $2.1M |
毛利率
ONTO
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | 50.7% | 53.2% | ||
| Q2 25 | 48.2% | 50.0% | ||
| Q1 25 | 53.7% | 53.6% | ||
| Q4 24 | 50.2% | 26.1% | ||
| Q3 24 | 54.1% | 50.0% | ||
| Q2 24 | 52.9% | 49.8% | ||
| Q1 24 | 51.7% | 49.5% |
营业利润率
ONTO
RGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | 10.9% | 8.9% | ||
| Q2 25 | 12.7% | 7.6% | ||
| Q1 25 | 23.7% | 3.9% | ||
| Q4 24 | 16.1% | -17.7% | ||
| Q3 24 | 21.0% | -5.1% | ||
| Q2 24 | 20.2% | 1.0% | ||
| Q1 24 | 18.7% | 1.3% |
净利率
ONTO
RGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 12.9% | 7.9% | ||
| Q2 25 | 13.4% | 8.2% | ||
| Q1 25 | 24.0% | 3.4% | ||
| Q4 24 | 18.5% | -17.4% | ||
| Q3 24 | 21.0% | -0.4% | ||
| Q2 24 | 21.9% | 2.2% | ||
| Q1 24 | 20.5% | 1.4% |
每股收益(稀释后)
ONTO
RGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | $0.57 | $0.26 | ||
| Q2 25 | $0.69 | $0.26 | ||
| Q1 25 | $1.30 | $0.10 | ||
| Q4 24 | $0.98 | $-0.55 | ||
| Q3 24 | $1.07 | $-0.01 | ||
| Q2 24 | $1.07 | $0.06 | ||
| Q1 24 | $0.94 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $603.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.0B | $2.1B |
| 总资产 | $2.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
ONTO
RGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | $603.1M | $748.7M | ||
| Q2 25 | $217.5M | $708.9M | ||
| Q1 25 | $203.7M | $697.2M | ||
| Q4 24 | $212.9M | $757.4M | ||
| Q3 24 | $188.7M | $784.0M | ||
| Q2 24 | $172.6M | $809.1M | ||
| Q1 24 | $190.9M | $780.6M |
总债务
ONTO
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
ONTO
RGEN
| Q4 25 | — | $2.1B | ||
| Q3 25 | $2.0B | $2.1B | ||
| Q2 25 | $2.0B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.9B | $2.0B | ||
| Q3 24 | $1.9B | $2.0B | ||
| Q2 24 | $1.8B | $2.0B | ||
| Q1 24 | $1.8B | $2.0B |
总资产
ONTO
RGEN
| Q4 25 | — | $2.9B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $2.1B | $2.9B | ||
| Q1 25 | $2.1B | $2.9B | ||
| Q4 24 | $2.1B | $2.8B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.0B | $2.9B | ||
| Q1 24 | $2.0B | $2.8B |
负债/权益比
ONTO
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $83.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $82.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 37.6% | 8.9% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 2.95× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $261.3M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
ONTO
RGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | $83.4M | $48.1M | ||
| Q2 25 | $57.9M | $28.6M | ||
| Q1 25 | $92.0M | $15.0M | ||
| Q4 24 | $56.0M | $39.2M | ||
| Q3 24 | $67.2M | $49.3M | ||
| Q2 24 | $65.3M | $42.2M | ||
| Q1 24 | $57.1M | $44.7M |
自由现金流
ONTO
RGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | $82.0M | $43.4M | ||
| Q2 25 | $44.2M | $21.5M | ||
| Q1 25 | $83.7M | $11.4M | ||
| Q4 24 | $51.4M | $33.6M | ||
| Q3 24 | $59.2M | $42.3M | ||
| Q2 24 | $53.0M | $37.4M | ||
| Q1 24 | $50.2M | $36.4M |
自由现金流率
ONTO
RGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | 37.6% | 23.0% | ||
| Q2 25 | 17.4% | 11.8% | ||
| Q1 25 | 31.4% | 6.8% | ||
| Q4 24 | 19.5% | 19.3% | ||
| Q3 24 | 23.5% | 27.3% | ||
| Q2 24 | 21.9% | 24.3% | ||
| Q1 24 | 21.9% | 24.0% |
资本支出强度
ONTO
RGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | 5.4% | 3.9% | ||
| Q1 25 | 3.1% | 2.1% | ||
| Q4 24 | 1.8% | 3.2% | ||
| Q3 24 | 3.2% | 4.5% | ||
| Q2 24 | 5.1% | 3.1% | ||
| Q1 24 | 3.0% | 5.5% |
现金转化率
ONTO
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 2.95× | 3.23× | ||
| Q2 25 | 1.71× | 1.92× | ||
| Q1 25 | 1.44× | 2.57× | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.23× | 12.70× | ||
| Q1 24 | 1.22× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ONTO
| Systems And Software Revenue | $173.8M | 80% |
| Parts Revenue | $23.9M | 11% |
| Service Revenue | $20.5M | 9% |
RGEN
暂无分部数据